Amgen Inc header image

Amgen Inc

AMGN

Equity

ISIN null / Valor 907582

NASDAQ (2026-02-27)
USD 388.16+2.33%

Amgen Inc
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

s a leading biotechnology company that focuses on addressing high unmet medical needs by developing innovative medicines to improve health outcomes and enhance the lives of patients worldwide. With a strong emphasis on science and innovation, Amgen leverages its expertise in understanding the biological mechanisms of disease to drive its discovery research efforts and build a deep pipeline of potential new medicines with breakthrough potential. Through its subsidiary deCODE Genetics, Amgen utilizes human genetics to identify and validate disease targets, further enhancing its research capabilities. As a global leader in biologics manufacturing, Amgen ensures the safe and reliable production of biologic medicines that are crucial for the treatment of millions of seriously ill patients. With a commitment to quality control and a reliable supply of medicines, Amgen's mission is to transform new ideas and discoveries into life-changing therapies for patients with serious illnesses.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

26.9%1Y
65.6%3Y
72.6%5Y

Performance

28.9%1Y
25.7%3Y
23.9%5Y

Volatility

Market cap

209245 M

Market cap (USD)

Daily traded volume (Shares)

3,441,042

Daily traded volume (Shares)

1 day high/low

261.55 / 258.74

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Zoe Holloway
United Kingdom, 07 Feb 2026
star star star star star
Steady upwards trend
Kendra Ho
United Kingdom, 06 Feb 2026
star star star star star
Overall good performance

EQUITIES OF THE SAME SECTOR

Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%EUR 50.90
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%EUR 39.45
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.11%USD 3.25
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 5.20
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 0.95
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.18%USD 22.74
iRhythm Technologies Inc
iRhythm Technologies Inc iRhythm Technologies Inc Valor: 34117792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.59%USD 133.75
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.87%CHF 130.50
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.83%CAD 25.25
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 248.43